ImageneBio, Inc. (IMA) Form 424B3 — Jun 17, 2026
ImageneBio filed a prospectus supplement relating to the offer and resale of 2,508,337 shares of common stock by selling stockholders. The shares are listed on the Nasdaq Capital Market under the ticker symbol “IMA” and had a last reported sales price of $5.45 on June 16, 2026. The filing supplements the prospectus dated April 2, 2026, and incorporates information from the company’s Form 8-K regarding its 2026 Annual Meeting of Stockholders held on June 16, 2026. At the meeting, stockholders approved the amendment and restatement of the 2025 Equity Incentive Plan to increase the aggregate number of authorized shares by 850,000 shares.
Key figures
- Offering Price
- $5.45
- Shares Offered
- 2508337
- Plan increase shares
- 850000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.